AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23255849 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent
Number of subjects: 788
Study 23255849 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stent
Number of subjects: 788
Study 23255849 — intervention group
Group type: COMPARATOR
Intervention: Untreated SB with baseline stenosis < 50%
Number of subjects: 788
Study 23255849 — intervention group
Group type: COMPARATOR
Intervention: Untreated SB
Number of subjects: 788
Study 23255849 — intervention group
Group type: EXPERIMENTAL
Intervention: Main branch (MB) stenosis at follow-up (%)
Number of subjects: 788
Study 21173515 — intervention group
Group type: EXPERIMENTAL
Intervention: Bucolome combination therapy (BC) - bucolome 300 mg/day
Number of subjects: 195
Study 21173515 — intervention group
Group type: COMPARATOR
Intervention: Warfarin monotherapy (WM)
Number of subjects: 195
Study 17706438 — intervention group
Group type: EXPERIMENTAL
Intervention: FlexMaster (FM) rotary NiTi instruments
Number of subjects: 55
Study 17706438 — intervention group
Group type: COMPARATOR
Intervention: EndoEze AET (EE) stainless steel oscillating instruments
Number of subjects: 55
Study 15741469 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral social skills training (combined treatment)
Number of subjects: 76
Study 15741469 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 76
Study 12197588 — intervention group
Group type: EXPERIMENTAL
Intervention: Active teaching methods in health education
Number of subjects: 0
Study 12197588 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (control)
Number of subjects: 0
Study 9704181 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermofilm (topical preparation)
Number of subjects: 50
Study 7818622 — intervention group
Group type: EXPERIMENTAL
Intervention: Acadesine high-dose infusion
Number of subjects: 116
Study 7818622 — intervention group
Group type: EXPERIMENTAL
Intervention: Acadesine low-dose infusion
Number of subjects: 116
Study 7818622 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 116
Study 2698947 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin (20 mg twice a day for 2 weeks; 40 mg twice a day for 6 weeks)
Number of subjects: 17
Study 2698947 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 2698947 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin
Number of subjects: 17
Study 1099490 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary antiseptics
Number of subjects: 0
Study 1099490 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 31796521 — intervention group
Group type: EXPERIMENTAL
Intervention: Tisotumab vedotin 2.0 mg/kg every 3 weeks until progressive disease, unacceptable toxicity, or consent withdrawal
Number of subjects: 55
Study 31796521 — intervention group
Group type: EXPERIMENTAL
Intervention: Independent review
Number of subjects: 55
Study 31318603 — intervention group
Group type: EXPERIMENTAL
Intervention: Informational video messaging
Number of subjects: 0
Study 31318603 — intervention group
Group type: EXPERIMENTAL
Intervention: Testimonial video messaging
Number of subjects: 0
Study 31318603 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended video messaging
Number of subjects: 0
Study 31318603 — intervention group
Group type: EXPERIMENTAL
Intervention: Video messaging (combined)
Number of subjects: 0
Study 31318603 — intervention group
Group type: COMPARATOR
Intervention: Historical comparison group (no video messaging)
Number of subjects: 0
Study 31318603 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended and informational messaging
Number of subjects: 0
Study 28442186 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training intervention
Number of subjects: 21
Study 28442186 — intervention group
Group type: COMPARATOR
Intervention: Attention-matched control training intervention
Number of subjects: 21
Study 27328489 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone
Number of subjects: 157
Study 27328489 — intervention group
Group type: COMPARATOR
Intervention: Control (Gestrinone)
Number of subjects: 157
Study 24596005 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg estradiol valerate and 2 mg dienogest
Number of subjects: 73
Study 24596005 — intervention group
Group type: COMPARATOR
Intervention: 2 mg estradiol valerate and 10 mg medroxyprogesterone acetate
Number of subjects: 73
Study 24596005 — intervention group
Group type: COMPARATOR
Intervention: Comparison between dienogest and medroxyprogesterone acetate
Number of subjects: 73
Study 22585765 — intervention group
Group type: EXPERIMENTAL
Intervention: O3FA
Number of subjects: 33
Study 22585765 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 19454879 — intervention group
Group type: EXPERIMENTAL
Intervention: Press needle (n=45)
Number of subjects: 90
Study 19454879 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=45)
Number of subjects: 90
Study 19454879 — intervention group
Group type: EXPERIMENTAL
Intervention: Press needle
Number of subjects: 90
Study 17444886 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan
Number of subjects: 108
Study 17444886 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 108
Study 16094020 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectus fascia sling
Number of subjects: 53
Study 16094020 — intervention group
Group type: COMPARATOR
Intervention: Tension-free vaginal tape (TVT)
Number of subjects: 53
Study 12100094 — intervention group
Group type: COMPARATOR
Intervention: 10 mg rizatriptan
Number of subjects: 56
Study 12100094 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg rizatriptan plus 25 mg rofecoxib
Number of subjects: 56
Study 10201675 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar sympathetic block
Number of subjects: 36
Study 10201675 — intervention group
Group type: COMPARATOR
Intervention: Epidural analgesia
Number of subjects: 36
Study 10201675 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 36
Study 7553241 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxymetazoline nasal spray with benzalkonium chloride
Number of subjects: 20
Study 7553241 — intervention group
Group type: COMPARATOR
Intervention: Oxymetazoline nasal spray without benzalkonium chloride
Number of subjects: 20
Study 2184635 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual anastomosis with monolayer polyglactin 910 sutures
Number of subjects: 48
Study 2184635 — intervention group
Group type: COMPARATOR
Intervention: Mechanical anastomosis with E.E.A. stapler
Number of subjects: 48
Study 7008367 — intervention group
Group type: EXPERIMENTAL
Intervention: Silymarin treatment
Number of subjects: 0
Study 7008367 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 31701699 — intervention group
Group type: EXPERIMENTAL
Intervention: γ-linolenic acid (GLA) 320 mg/day
Number of subjects: 100
Study 31701699 — intervention group
Group type: COMPARATOR
Intervention: α-lipoic acid (ALA) 600 mg/day
Number of subjects: 100
Study 31264032 — intervention group
Group type: EXPERIMENTAL
Intervention: Flare management intervention guided by non-physician providers
Number of subjects: 150
Study 31264032 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 150
Study 28643377 — intervention group
Group type: EXPERIMENTAL
Intervention: Community health workers (CHWs) intervention with home visits and tailored text message reminders
Number of subjects: 28
Study 28643377 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported adherence
Number of subjects: 28
Study 28643377 — intervention group
Group type: EXPERIMENTAL
Intervention: CHWs support
Number of subjects: 28
Study 25748566 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized pentoxifylline (20 mg/kg every 6 hours for 10 days)
Number of subjects: 81
Study 25748566 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline, equal volume every 6 hours for 10 days)
Number of subjects: 81
Study 25748566 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (pentoxifylline and placebo)
Number of subjects: 81
Study 24218465 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited oxygen strategy (LOX)
Number of subjects: 88
Study 24218465 — intervention group
Group type: COMPARATOR
Intervention: High oxygen strategy (HOX)
Number of subjects: 88
Study 22321931 — intervention group
Group type: EXPERIMENTAL
Intervention: FICB with ropivacaine 0.2%, 1 ml/kg, max. 30 ml
Number of subjects: 64
Study 22321931 — intervention group
Group type: COMPARATOR
Intervention: FICB with 0.9% normal saline 1 ml/kg, max. 30 ml
Number of subjects: 64
Study 19390463 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal estriol (1 mg) and progesterone (30 mg) suppositories
Number of subjects: 19
Study 16318995 — intervention group
Group type: EXPERIMENTAL
Intervention: Externally induced acute pain
Number of subjects: 8
Study 16318995 — intervention group
Group type: COMPARATOR
Intervention: Rest
Number of subjects: 8
Study 15636225 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma homocysteine levels in AMD patients
Number of subjects: 30
Study 15636225 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma vitamin B12 concentration in AMD patients
Number of subjects: 30
Study 15636225 — intervention group
Group type: EXPERIMENTAL
Intervention: Red blood cell folic acid concentration in AMD patients
Number of subjects: 30
Study 15636225 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma folic acid concentration in AMD patients
Number of subjects: 30
Study 10615231 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole (200 micrograms/day)
Number of subjects: 109
Study 10615231 — intervention group
Group type: COMPARATOR
Intervention: Nystatin (6,000,000 IU/day)
Number of subjects: 109
Study 7898595 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise and weight loss
Number of subjects: 0
Study 2383027 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional sustained release interferon alfa‐2b (10 million IU per injection) - 3 injections
Number of subjects: 65
Study 2383027 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional sustained release interferon alfa‐2b (10 million IU per injection) - 1 injection
Number of subjects: 65
Study 6894277 — intervention group
Group type: COMPARATOR
Intervention: Placebo phase of a randomised double blind ergometry study
Number of subjects: 10
Study 31163231 — intervention group
Group type: EXPERIMENTAL
Intervention: FMX101 4% topical minocycline foam
Number of subjects: 1488
Study 31163231 — intervention group
Group type: COMPARATOR
Intervention: Foam vehicle (control)
Number of subjects: 1488
Study 29935326 — intervention group
Group type: EXPERIMENTAL
Intervention: i-scan 1 (surface and contrast enhancement)
Number of subjects: 740
Study 29935326 — intervention group
Group type: COMPARATOR
Intervention: HDWL colonoscopy
Number of subjects: 740
Study 28160190 — intervention group
Group type: EXPERIMENTAL
Intervention: CKD-712 160 µg/kg
Number of subjects: 44
Study 28160190 — intervention group
Group type: EXPERIMENTAL
Intervention: CKD-712 320 µg/kg
Number of subjects: 44
Study 28160190 — intervention group
Group type: EXPERIMENTAL
Intervention: CKD-712 (20 to 240 µg/kg)
Number of subjects: 44
Study 28160190 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 24923535 — intervention group
Group type: EXPERIMENTAL
Intervention: Inclined stool (20°)
Number of subjects: 2
Study 24923535 — intervention group
Group type: COMPARATOR
Intervention: Flat stool
Number of subjects: 2
Study 22842478 — intervention group
Group type: EXPERIMENTAL
Intervention: IMA901
Number of subjects: 96
Study 22842478 — intervention group
Group type: COMPARATOR
Intervention: Single dose of cyclophosphamide
Number of subjects: 96
Study 22842478 — intervention group
Group type: EXPERIMENTAL
Intervention: Myeloid-derived suppressor cells
Number of subjects: 96
Study 22842478 — intervention group
Group type: EXPERIMENTAL
Intervention: Apolipoprotein A‐I (APOA1) and chemokine (C‐C motif) ligand 17 (CCL17)
Number of subjects: 96
Study 20732868 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxin (four doses)
Number of subjects: 232
Study 20732868 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 232
Study 16690006 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose venlafaxine (75 mg/d)
Number of subjects: 44
Study 16690006 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose venlafaxine (up to 375 mg/d)
Number of subjects: 44
Study 16690006 — intervention group
Group type: EXPERIMENTAL
Intervention: Both low and high doses of venlafaxine
Number of subjects: 44
Study 16225720 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol alone (Group P)
Number of subjects: 240
Study 16225720 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol with midazolam 0.1 mg kg(‐1) (Group PM)
Number of subjects: 240
Study 16225720 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol with fentanyl 1 mug kg‐1 (Group PF)
Number of subjects: 240
Study 16225720 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol with midazolam (Group PM)
Number of subjects: 240
Study 16225720 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol with fentanyl (Group PF)
Number of subjects: 240
Study 12400430 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 216
Study 12400430 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 216
Study 12400430 — intervention group
Group type: COMPARATOR
Intervention: Sham acupressure (placebo)
Number of subjects: 216
Study 10420139 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged occlusion for 24, 48, 72, and 96 hours
Number of subjects: 12
Study 10420139 — intervention group
Group type: COMPARATOR
Intervention: Control (no occlusion)
Number of subjects: 12
Study 8523658 — intervention group
Group type: EXPERIMENTAL
Intervention: Deeply anesthetized extubation group (anesthetized group)
Number of subjects: 30
Study 8523658 — intervention group
Group type: COMPARATOR
Intervention: Awake extubation group (awake group)
Number of subjects: 30
Study 2246304 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed suction drains
Number of subjects: 70
Study 2246304 — intervention group
Group type: COMPARATOR
Intervention: No drains (control)
Number of subjects: 70
Study 6124087 — intervention group
Group type: EXPERIMENTAL
Intervention: Infra-red stimulation using IRS Medtec 100
Number of subjects: 26
Study 6124087 — intervention group
Group type: COMPARATOR
Intervention: Mock TNS (placebo)
Number of subjects: 26
Study 31863040 — intervention group
Group type: EXPERIMENTAL
Intervention: Recommendation of root canal treatment for White patients (86.21%)
Number of subjects: 57
Study 31863040 — intervention group
Group type: COMPARATOR
Intervention: Recommendation of extraction for Black patients (60.71%)
Number of subjects: 57
Study 31863040 — intervention group
Group type: EXPERIMENTAL
Intervention: BIAT scores indicating implicit racial bias
Number of subjects: 57
Study 28862883 — intervention group
Group type: COMPARATOR
Intervention: R-CHOP
Number of subjects: 206
Study 28862883 — intervention group
Group type: EXPERIMENTAL
Intervention: VR-CHOP (R-CHOP + bortezomib 1.3 mg/m2 on days 1 and 4)
Number of subjects: 206
Study 28862883 — intervention group
Group type: EXPERIMENTAL
Intervention: VR-CHOP
Number of subjects: 206
Study 26150019 — intervention group
Group type: EXPERIMENTAL
Intervention: 5000 step goal
Number of subjects: 94
Study 26150019 — intervention group
Group type: EXPERIMENTAL
Intervention: 10,000 step goal
Number of subjects: 94
Study 26150019 — intervention group
Group type: EXPERIMENTAL
Intervention: Switch from 5000 to 10,000 steps
Number of subjects: 94
Study 26150019 — intervention group
Group type: EXPERIMENTAL
Intervention: Switch from 10,000 to 5000 steps
Number of subjects: 94
Study 24444988 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg/hr of ketamine and 2 mg/kg/hr of propofol
Number of subjects: 60
Study 24444988 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 60
Study 23646099 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg LD-¹³C with randomized CD doses (0, 25, 50, 100 and 200 mg)
Number of subjects: 6
Study 23646099 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg LD-¹³C with increasing CD doses
Number of subjects: 6
Study 23646099 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg LD-¹³C
Number of subjects: 6
Study 23646099 — intervention group
Group type: EXPERIMENTAL
Intervention: LD-breath test
Number of subjects: 6
Study 19356374 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxymetholone 50 mg orally twice daily for 24 weeks
Number of subjects: 44
Study 19356374 — intervention group
Group type: COMPARATOR
Intervention: Placebo twice daily for 24 weeks
Number of subjects: 44
Study 18080043 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic field (PEMF) treatment (400 microT), twice-daily 40 min treatments over seven days
Number of subjects: 32
Study 18080043 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (placebo)
Number of subjects: 32
Study 16805716 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive statin therapy (high doses)
Number of subjects: 0
Study 16805716 — intervention group
Group type: EXPERIMENTAL
Intervention: Less intensive statin therapy
Number of subjects: 0
Study 16805716 — intervention group
Group type: COMPARATOR
Intervention: Statins (general)
Number of subjects: 0
Study 15242434 — intervention group
Group type: EXPERIMENTAL
Intervention: Double injection of 15 ml of 0.75% ropivacaine to each sciatic nerve component (total 30 ml)
Number of subjects: 50
Study 15242434 — intervention group
Group type: COMPARATOR
Intervention: Single injection of 30 ml of 0.75% ropivacaine to the sciatic nerve
Number of subjects: 50
Study 15242434 — intervention group
Group type: COMPARATOR
Intervention: Single injection
Number of subjects: 50
Study 10914438 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited excision and open wound healing (group B)
Number of subjects: 100
Study 10914438 — intervention group
Group type: COMPARATOR
Intervention: Excision and primary suture (group B)
Number of subjects: 100
Study 10914438 — intervention group
Group type: EXPERIMENTAL
Intervention: Excision and open wound healing (group A)
Number of subjects: 100
Study 8620641 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment (primary repair plus early controlled mobilization)
Number of subjects: 60
Study 8620641 — intervention group
Group type: COMPARATOR
Intervention: Functional treatment (early controlled mobilization alone)
Number of subjects: 60
Study 8620641 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 60
Study 8620641 — intervention group
Group type: COMPARATOR
Intervention: Functional treatment
Number of subjects: 60
Study 1627756 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium chloride (120 mmol/day)
Number of subjects: 22
Study 1627756 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 6518782 — intervention group
Group type: EXPERIMENTAL
Intervention: Marker methodology
Number of subjects: 0
Study 6518782 — intervention group
Group type: COMPARATOR
Intervention: Current methodology
Number of subjects: 0
Study 30897499 — intervention group
Group type: EXPERIMENTAL
Intervention: Family interactions around food (less positive)
Number of subjects: 162
Study 30897499 — intervention group
Group type: EXPERIMENTAL
Intervention: Family expressiveness (more)
Number of subjects: 162
Study 28899910 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 hours of hyperoxia (end‐tidal PO2 = 420 mmHg)
Number of subjects: 11
Study 28899910 — intervention group
Group type: COMPARATOR
Intervention: 8 hours of euoxia (end‐tidal PO2 = 100 mmHg)
Number of subjects: 11
Study 26594944 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioral therapy (CBT)
Number of subjects: 85
Study 26594944 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy (IPT)
Number of subjects: 85
Study 26594944 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioral therapy (CBT) and Interpersonal psychotherapy (IPT)
Number of subjects: 85
Study 25057969 — intervention group
Group type: EXPERIMENTAL
Intervention: Theory of Planned Behavior constructs (attitude, subjective norm, perceived behavioral control)
Number of subjects: 169
Study 25057969 — intervention group
Group type: EXPERIMENTAL
Intervention: Intent to abstain from smoking (predicted by TPB)
Number of subjects: 169
Study 25057969 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived Behavioral Control (PBC)
Number of subjects: 169
Study 25057969 — intervention group
Group type: EXPERIMENTAL
Intervention: TPB constructs (attitude and PBC)
Number of subjects: 169
Study 23108941 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary intervention program
Number of subjects: 75
Study 23108941 — intervention group
Group type: COMPARATOR
Intervention: Usual-care program
Number of subjects: 75
Study 19577636 — intervention group
Group type: EXPERIMENTAL
Intervention: Subvirion avian influenza A/H5N1 vaccine with aluminum hydroxide (AlOH)
Number of subjects: 600
Study 19577636 — intervention group
Group type: EXPERIMENTAL
Intervention: Subvirion avian influenza A/H5N1 vaccine without aluminum hydroxide (AlOH)
Number of subjects: 600
Study 19577636 — intervention group
Group type: EXPERIMENTAL
Intervention: Subvirion avian influenza A/H5N1 vaccine (all doses)
Number of subjects: 600
Study 19577636 — intervention group
Group type: EXPERIMENTAL
Intervention: Subvirion avian influenza A/H5N1 vaccine (45microg HA)
Number of subjects: 600
Study 19577636 — intervention group
Group type: EXPERIMENTAL
Intervention: Subvirion avian influenza A/H5N1 vaccine (45microg HA with AlOH)
Number of subjects: 600
Study 17216334 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted HIV prevention intervention for psychiatric patients in Brazil
Number of subjects: 0
Study 15204280 — intervention group
Group type: EXPERIMENTAL
Intervention: Upward loading with different load magnitudes (250, 750, and 1250 g) during five- and three-digit grasps.
Number of subjects: 0
Study 15204280 — intervention group
Group type: EXPERIMENTAL
Intervention: Downward loading with different load magnitudes (250, 750, and 1250 g) during five- and three-digit grasps.
Number of subjects: 0
Study 11579363 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril monotherapy
Number of subjects: 57
Study 11579363 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol monotherapy
Number of subjects: 57
Study 11579363 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (Captopril + Carvedilol)
Number of subjects: 57
Study 9795022 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal suppository
Number of subjects: 0